fbpx
Exactech Shoulder Equinoxe Planning App

Equinoxe Planning App

Link pre-op plans to real-time intra-op instrument guidance.

Equinoxe Shoulder Planning App v2.1 allows surgeons to assess shoulder range of motion and impingement.

Allows true execution of preoperative plan and visual recording of implant placement | Verified implant placement

Exactech Active Intelligence Newton Knee Planning

Newton Knee Planning

Full-range personalized planning for ligament-driven balancing.

Newton Knee Soft Tissue Balancing Technology

Introducing the Newton Knee, a dynamic platform of cutting-edge technology and forward-thinking implants designed to provide optimal balance in a reproducible way.

Exactech Active Intelligence Shoulder GPS

GPS Shoulder

See into the shoulder with real-time navigation.

From planning to placement, Planning App + ExactechGPS Shoulder gives surgeons control before and during surgery

First and only shoulder navigation technology that connects the preoperative plan with real-time intraoperative instrument guidance and verifies implant placement.

 

Exactech ExactechGPS Ankle

GPS Ankle

The world’s first surgical navigation system for total ankle arthroplasty (TAA)

ExactechGPS® Ankle, the world’s first surgical navigation system for TAA, has received 510(k) clearance.

Exactech ExactechGPS Ankle

This first-of-its-kind technology connects the preoperative plan with real-time intraoperative instrument guidance and confirms that resections meet the surgical plan.

Pre-clinical studies, based on bench testing, reported an accuracy of 2mm and 2 degrees relative to the CT-based surgical plan.1 This was further confirmed by two studies performed on sawbones, which were recently accepted by the Orthopaedic Research Society. 2-3

GPS Ankle is only available in the U.S. and will enter pilot launch with limited availability starting in 2024.

References:

  1. Data on file.
  2. Rueff M. et al. Accuracy and Precision Evaluation of Image-based Computer Assisted Surgical System for Total Ankle Arthroplasty. 2023. Accepted to ORS.
  3. Rueff M. et al. Evaluation of error sources for an Image-based Computer Assisted Surgical System for Total Ankle Arthroplasty. 2023. Accepted to ORS.

GPS, Equinoxe Planning App and Predict+ are developed by Blue Ortho, an Exactech subsidiary, and distributed by Exactech, Inc.

Exactech Active Intelligence Newton Knee

Newton Knee Balancing

Pre-resection operative insights and soft tissue analytics to help simplify, evaluate and execute balanced results.

Balancing bodies in motion.

Introducing the Newton Knee, a dynamic platform of cutting-edge technology and forward-thinking implants designed to provide optimal balance in a reproducible way.

Exactech Active Intelligence Vantage Ankle PSI

Ankle PSI

Pre-plan resections, view deformities and determine implant sizing.

A Perspective Beyond

Created using advanced technologies, the Vantage® Ankle PSI 3D-printed tibia and talar cutting guides are designed for patients’ unique anatomies. The cutting guides allow surgeons to pre-plan, are part of Exactech’s Active Intelligence® initiative and are used exclusively with the Vantage Total Ankle System.

Exactech Active Intelligence Predict+

Predict+

Leverage predictive analytics and patient data from thousands of cases to predict success.

Patient-Specific Outcome Predictor

Leverage predictive analytics and patient data from thousands of cases to predict success. Exactech’s new Predict+™ is a data-driven, clinical decision support tool that uses machine learning to provide predictions of individual patient outcomes after shoulder replacement

Exactech Chime Surgeon Clinical App

Chime

Get and share expertise with shoulder, hip, knee and ankle surgeons worldwide.

Exclusive to Exactech’s shoulder, ankle, hip and knee surgeons worldwide.

Download the Chime app to enter Exactech’s world of clinical exchange and case discussions. Get and share expertise with shoulder, hip, knee and ankle surgeons worldwide. Chime in yourself by posing a question, launching a poll, or joining in on discussions

Predict+ has not received FDA marketing authorization